Non-Current Assets

Equity Securities (FV-NI) - Non-Current

Regeneron Pharmaceuticals Equity Securities (FV-NI) - Non-Current increased by 42.0% to $48.70M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2025
Last reportedQ1 2026Apr 29, 2026
Metric ID: equity_securities_fvni_noncurrent

Historical Data

2 periods
 Q4 '25Q1 '26
Value$34.30M$48.70M
QoQ Change—+42.0%
Range$34.30M – $48.70M

Equity Securities (FV-NI) - Non-Current at Other Companies

Amgen logo
AmgenAMGNView metric

Frequently Asked Questions

What is Regeneron Pharmaceuticals's equity securities (fv-ni) - non-current?
Regeneron Pharmaceuticals (REGN) reported equity securities (fv-ni) - non-current of $48.70M in Q1 2026.